PATJ activators are a category of chemicals that modulate the activity of the PALS1-associated tight junction protein, commonly known as PATJ. PATJ is an important scaffolding molecule that participates in the assembly and maintenance of tight junctions in epithelial and endothelial cells, which are crucial for the establishment and regulation of barriers controlling paracellular transport and cellular polarity.
Direct activators of PATJ may interact with the protein to bolster its role in the tight junction complex. This could involve enhancing its interaction with other tight junction components, such as PALS1 (protein associated with Lin7, Scribble cell polarity complex component), or with transmembrane proteins like claudins and occludins, which are integral to the function of tight junctions. Through direct interaction, these activators could stabilize PATJ within the complex, potentially leading to a more robust tight junction assembly and improved barrier function. Indirect activators of PATJ could operate by upregulating the expression of the PATJ gene, thus increasing the protein levels and enhancing the integrity of tight junctions. Alternatively, they may inhibit pathways that lead to the degradation or mislocalization of PATJ, ensuring that a greater proportion of the protein is correctly situated and active at the tight junction. Indirect activators could also influence the post-translational modifications of PATJ, such as phosphorylation, which may affect its binding properties or interaction with other cellular machinery involved in the maintenance of cell polarity and junctional integrity.
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
PGE2 is a potent activator of the EP2 and EP4 receptors, which are known to increase the intracellular cAMP levels. Increased cAMP levels can activate PKA, which then phosphorylates and activates PATJ. |